Occudo Quantitative Strategies LP Kezar Life Sciences, Inc. Transaction History
Occudo Quantitative Strategies LP
- $542 Million
- Q2 2024
A detailed history of Occudo Quantitative Strategies LP transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 12,147 shares of KZR stock, worth $6,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,147
Previous 31,769
61.76%
Holding current value
$6,559
Previous $28,000
75.0%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding KZR
# of Institutions
83Shares Held
39.6MCall Options Held
3.2KPut Options Held
700-
Suvretta Capital Management, LLC New York, NY7.17MShares$3.87 Million0.18% of portfolio
-
Avidity Partners Management LP Dallas, TX5.03MShares$2.71 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$1.48 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.05MShares$1.11 Million0.18% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.93MShares$1.04 Million0.03% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $36.9M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...